Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHO-A04 in Advanced Solid Tumors
NCT07049458Phase 2Not yet recruiting
- Sponsor
- CHO Pharma
- Start
- Jul 2027
- Primary completion
- Dec 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CHO-A04 in solid tumor, sponsored by CHO Pharma. Planned start Jul 2027; status: not yet recruiting.
02
Drugs
CHO-A04
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07049458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07049458.